IL6 and neoplasm: In ENKTCL, MSCs may protect tumor cells from apoptosis by secreting soluble anti-apoptotic factors (e.g., IL-6, CXCL12), altering drug metabolism in the LME and physically shielding tumor cells through the formation of protective stromal niches [65,66].